ATE2392T1 - Verfahren zur herstellung eines rhesusantigens, arzneimittel und pharmazeutische zusammensetzungen, die das antigen enthalten, und verabreichungsformen. - Google Patents

Verfahren zur herstellung eines rhesusantigens, arzneimittel und pharmazeutische zusammensetzungen, die das antigen enthalten, und verabreichungsformen.

Info

Publication number
ATE2392T1
ATE2392T1 AT80401540T AT80401540T ATE2392T1 AT E2392 T1 ATE2392 T1 AT E2392T1 AT 80401540 T AT80401540 T AT 80401540T AT 80401540 T AT80401540 T AT 80401540T AT E2392 T1 ATE2392 T1 AT E2392T1
Authority
AT
Austria
Prior art keywords
antigen
preparation
solution
medications
processes
Prior art date
Application number
AT80401540T
Other languages
English (en)
Inventor
Simone Bierme
Madeleine Blanc
Michel Abbal
Alain Fournie
Original Assignee
Oeuvre Regionale De Transfusion Sanguine De Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oeuvre Regionale De Transfusion Sanguine De Toulouse filed Critical Oeuvre Regionale De Transfusion Sanguine De Toulouse
Application granted granted Critical
Publication of ATE2392T1 publication Critical patent/ATE2392T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT80401540T 1979-10-31 1980-10-30 Verfahren zur herstellung eines rhesusantigens, arzneimittel und pharmazeutische zusammensetzungen, die das antigen enthalten, und verabreichungsformen. ATE2392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7927080A FR2473312A1 (fr) 1979-10-31 1979-10-31 Preparation d'antigene rhesus administrable par voie orale, utile pour le traitement des formes graves d'immunisation rh
EP80401540A EP0030172B1 (de) 1979-10-31 1980-10-30 Verfahren zur Herstellung eines Rhesusantigens, Arzneimittel und pharmazeutische Zusammensetzungen, die das Antigen enthalten, und Verabreichungsformen

Publications (1)

Publication Number Publication Date
ATE2392T1 true ATE2392T1 (de) 1983-03-15

Family

ID=9231251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80401540T ATE2392T1 (de) 1979-10-31 1980-10-30 Verfahren zur herstellung eines rhesusantigens, arzneimittel und pharmazeutische zusammensetzungen, die das antigen enthalten, und verabreichungsformen.

Country Status (4)

Country Link
EP (1) EP0030172B1 (de)
AT (1) ATE2392T1 (de)
DE (1) DE3061921D1 (de)
FR (1) FR2473312A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106110421B (zh) * 2016-07-01 2019-02-01 翁炳焕 恒河猴红细胞吸附器

Also Published As

Publication number Publication date
EP0030172B1 (de) 1983-02-09
FR2473312A1 (fr) 1981-07-17
FR2473312B1 (de) 1983-03-25
DE3061921D1 (en) 1983-03-17
EP0030172A1 (de) 1981-06-10

Similar Documents

Publication Publication Date Title
Stone Comparison of the Action of V. cholerae Enzyme and of Viruses on the Red Cell Surface.
Landy et al. Antibody production by leucocytes in peripheral blood
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
Fujiwara et al. Induction of tumour immunity with tumour cells treated with extract of garlic (Allium sativum)
Lee et al. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71
Hall et al. Human plasma and urine quinine levels following tablets, capsules, and intravenous infusion
Viza et al. Solubilization and partial purification of human leukaemic specific antigens
DE MAEYER-GUIGNARD et al. Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer
ATE2392T1 (de) Verfahren zur herstellung eines rhesusantigens, arzneimittel und pharmazeutische zusammensetzungen, die das antigen enthalten, und verabreichungsformen.
ATE72120T1 (de) Verwendung von petasites-extrakten zur herstellung eines arzneimittels zur behandlung von gastrointestinalen erkrankungen.
Fenichel et al. Immunomodulating and Antimetastatic Activity of 3–(P-Chlorophenyl) Thiazolo [3, 2-A] Benzimidazole-2-Acetic Acid (Wy-18, 251, Nsc 310633)
US4039656A (en) Production of attenuated viruses
US2386725A (en) Therapeutic substance for measles
DE2616406B2 (de) Mittel zur Prophylaxe und Therapie der Gastro-Enteritis
GB1404225A (en) Extraction of physiologically active substrates from parathyroid
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
LE BOUVIER Physicochemical characteristics of rubella antigens theta and iota
ATE79404T1 (de) Verfahren zur herstellung von hepatitis-b-virus- innenkoerperantigen (hbcag) in hefe.
Yu The response of human early and late rosette-forming lymphocytes to mixed and autologous lymphocyte culture and mitogens
DE3787927T2 (de) Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken.
GB1441752A (en) Preparation of human or other purified albumin
Greger et al. Micro-electrophoresis of human white cells and platelets
RU2144379C1 (ru) Противовирусный препарат и способ получения иммуноглобулина для профилактики и лечения вирусных заболеваний
Sprince et al. An Analysis of Tobacco Mosaic Virus for Biotin, Riboflavin and Pantothenic Acid
Murray Early ‘enzyme’Rh antibodies and second pregnancies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee